Galapagos NV ADR (NYSE: GLPG) — Healthcare · Share Price, Chart & Market Data
About: Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that is in phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Sector: Healthcare
Industry: Biotechnology
Latest price: $28.60 (-0.28%)
GLPGGalapagos NV ADR
Loading watchlist status…
Trade GLPG now
Galapagos NV ADR share price
GLPG price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:33 am GMT+0
GLPG price performance
-1.072%
5D
-1.141%
1M
-13.254%
YTD
6.438%
1Y
GLPG price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:33 am GMT+0
GLPG details
GLPG Market Signals